0001048477-24-000079.txt : 20240513 0001048477-24-000079.hdr.sgml : 20240513 20240513155727 ACCESSION NUMBER: 0001048477-24-000079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240509 FILED AS OF DATE: 20240513 DATE AS OF CHANGE: 20240513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES CENTRAL INDEX KEY: 0001221590 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 24938793 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 wk-form4_1715630235.xml FORM 4 X0508 4 2024-05-09 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001221590 BIENAIME JEAN JACQUES C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO STREET SAN RAFAEL CA 94901 1 0 0 0 1 Common Stock 2024-05-09 4 M 0 20000 63.10 A 494994 D Common Stock 2024-05-09 4 S 0 20000 81.62 D 474994 D Common Stock 2024-05-10 4 M 0 20000 63.10 A 494994 D Common Stock 2024-05-10 4 S 0 20000 81.14 D 474994 D Common Stock 247333 I Shares held by Jean-Jacques Bienaime Family Trust Common Stock 100 I Shares held as UTMA custodian for child 1 Common Stock 100 I Shares held as UTMA custodian for child 2 Stock Option (Right to Buy Common Stock) 63.10 2024-05-09 4 M 0 20000 0 D 2014-12-04 2024-06-03 Common Stock 20000 71000 D Stock Option (Right to Buy Common Stock) 63.10 2024-05-10 4 M 0 20000 0 D 2014-12-04 2024-06-03 Common Stock 20000 51000 D Trade made pursuant to a 10b5-1 plan executed on August 7, 2023. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Tae Sang Yoo, Attorney-in-Fact 2024-05-13